Yes. EPCLUSA can be used to treat adults with chronic hepatitis C genotype 1-6 infection with or without cirrhosis (compensated), or with advanced cirrhosis (decompensated) in combination with ribavirin. Learn more about EPCLUSA efficacy and safety across levels of liver impairment.